Methods of model calibration: Observations from a mathematical model of cervical cancer

PharmacoEconomics

Volumn 28, Issue 11, 2010, Pages 995-1000

  Taylor, Douglas C A ^a   Pawar, Vivek ^a   Kruzikas, Denise ^b   Gilmore, Kristen E ^a   Pandya, Ankur ^c   Iskandar, Rowan ^d   Weinstein, Milton C ^a,c  

^a i3 Global   (Canada)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cervical cancer; human papillomavirus infections; modelling; treatment

Indexed keywords

ARTICLE; CALIBRATION; COMPARATIVE STUDY; MANUAL CALIBRATION; MATHEMATICAL MODEL; NELDER MEAD CALIBRATION; PAPILLOMAVIRUS INFECTION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; UTERINE CERVIX CANCER; VALIDITY; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CALIBRATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPUTER SIMULATION; ECONOMICS, PHARMACEUTICAL; FEMALE; HUMANS; MARKOV CHAINS; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77957996729     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11538660-000000000-00000     Document Type: Article

References (16)

1. US National Institutes of Health, National Cancer Institute. Human papillomavirus (HPV) vaccines [National Cancer Institute factsheet; online]. Available from URL: http://www.cancer.gov/cancertopics/factsheet/Prevention/HPV- vaccine [Accessed 2009 Dec. 4]
2. Munoz N, Bosch FX, Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9
3. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65 (Pubitemid 34293391)
4. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64
5. Kjaer S, Van Den Brule A, Bock JE, et al. Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6
6. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6
7. Kohli M, Ferko N, Martin A, et al. Estimating the long term impact of prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Brit J Cancer 2007;96:143-50
8. Benard V, Eheman C, Lawson H, et al. Cervical screening in the national breast and cervical cancer early detection program, 1995-2000. Obstet Gynecol 2004;103(3):564-71
9. Surveillance Epidemiology and End Results (SEER), National Cancer Institute. Fast stats: an interactive tool for access to SEER cancer statistics [online]. Available from URL: http://seer.cancer.gov/faststats [Accessed 2009 Jan 1]
10. Kim JJ, Kuntz KM, Stout NK, et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 2007;166(2):137-50
11. Van de Velde N, Brisson M, Boily M. Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol 2006;165:762-75
12. Nelder J, Mead R. A simplex method for function minimization. Compute J 1965;7:308-13
13. Lewis RM, Torczon V, Trosset MW. Direct search methods: then and now. J Comput Appl Math 2000;124(1-2): 191-207
14. Solomatine DP. Random search methods in model calibration and pipe network design. In: Savic DA, Walters GS. Water industry systems: modelling and optimization applications. Vol. 2. Baldock: Research Studies Press, Ltd, 1999:317-32
15. Iman RL, Helton JC, Campbell JE. An approach to sensitivity analysis of computer models: part I. Introduction, input variable selection and preliminary variable assessment. J Quality Technol 1981;13:174-83
16. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice of decision analytic modeling in health care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health 2003;6:9-17